Abstract:Alzheimer's disease (AD) is the most prevalent neurodegenerative disease, affecting more than 55 million individuals worldwide in 2021. In addition to the "amyloid hypothesis," an increasing number of studies have demonstrated that phosphorylated tau plays an important role in AD pathogenesis. Both soluble tau oligomers and insoluble tau aggregates in the brain can induce structural and functional neuronal damage through multiple pathways, eventually leading to memory deficits and neurodegeneration. Autophagy is an important cellular response to various stress stimuli and can generally be categorized into non-selective and selective autophagy. Recent studies have indicated that both types of autophagy are involved in AD pathology. Among the several subtypes of selective autophagy, mitophagy, which mediates the selective removal of mitochondria, has attracted increasing attention because dysfunctional mitochondria have been suggested to contribute to tauopathies. In this review, we summarize the latest findings on the bidirectional association between abnormal tau proteins and defective autophagy, as well as mitophagy, which might constitute a vicious cycle in the induction of neurodegeneration. Neuroinflammation, another important feature in the pathogenesis and progression of AD, has been shown to crosstalk with autophagy and mitophagy. Additionally, we comprehensively discuss the relationship between neuroinflammation, autophagy, and mitophagy. By elucidating the underlying molecular mechanisms governing these pathologies, we highlight novel therapeutic strategies targeting autophagy, mitophagy and neuroinflammation, such as those using rapamycin, urolithin, spermidine, curcumin, nicotinamide, and actinonin, for the prevention and treatment of AD.

The Role of Autophagy in Alzheimer's Disease and Its Potential for Therapy

Autophagy Modulation for Alzheimer's Disease Therapy.

Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer’s Disease

Autophagy in Alzheimer's Disease Pathogenesis: Therapeutic Potential and Future Perspectives.

Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential

Autophagy in Alzheimer’s disease pathogenesis: Therapeutic potential and future perspectives

Targeting Autophagy for the Treatment of Alzheimer’s Disease: Challenges and Opportunities

Autophagy and Its Comprehensive Impact on ALS

The emerging role of autophagy and mitophagy in tauopathies: From pathogenesis to translational implications in Alzheimer's disease

Exploring the bi‐directional relationship between autophagy and Alzheimer’s disease

Stimulation of autophagy prevents amyloid-β peptide-induced neuritic degeneration in PC12 cells.

Defective Autophagy and Mitophagy in Alzheimer's Disease: Mechanisms and Translational Implications

The Potential Role of miRNA-Regulated Autophagy in Alzheimer's Disease

A Tauopathy-Homing and Autophagy-Activating Nanoassembly for Specific Clearance of Pathogenic Tau in Alzheimer's Disease.

Autophagy in Alzheimer's Disease and Promising Modulatory Effects of Herbal Medicine

Autophagy in Aging and Neurodegenerative Diseases: Implications for Pathogenesis and Therapy.

The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer’s disease

Autophagy-lysosomal pathway impairment and cathepsin dysregulation in Alzheimer's disease

A review of autophagy mechanism of statins in the potential therapy of Alzheimer's disease

Mechanistic Insights into Selective Autophagy Subtypes in Alzheimer’s Disease

Dynamic changes of autophagic flux induced by Abeta in the brain of postmortem Alzheimer’s disease patients, animal models and cell models